严重急性呼吸综合征冠状病毒2感染与上肢深静脉血栓形成风险
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.
作者信息
Bozzani Antonio, Arici Vittorio, Franciscone Mila Maria, Danesino Vittorio, Cascina Alessandro, Ticozzelli Giulia, Ragni Franco
机构信息
Vascular and Endovascular Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Vascular and Endovascular Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
出版信息
Ann Vasc Surg. 2020 Jul;66:11-13. doi: 10.1016/j.avsg.2020.04.037. Epub 2020 Apr 23.
Abstract
Little or nothing is known about the correlation between the upper limb deep vein thrombosis (UL-DVT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the increased risk of UL-DVT in 3 patients with SARS-CoV-2 who require continuous positive airway pressure with a hood and the need for early adequate antithrombotic prophylaxis.
摘要
关于上肢深静脉血栓形成（UL-DVT）与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）之间的相关性，目前知之甚少。我们描述了3例需要使用头罩进行持续气道正压通气的SARS-CoV-2患者发生UL-DVT的风险增加，以及早期进行充分抗血栓预防的必要性。
相似文献
1
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.严重急性呼吸综合征冠状病毒2感染与上肢深静脉血栓形成风险
Ann Vasc Surg. 2020 Jul;66:11-13. doi: 10.1016/j.avsg.2020.04.037. Epub 2020 Apr 23.
2
Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19.COVID-19 阳性患者伴出血性静脉梗死的非典型深部脑静脉血栓形成。
AJNR Am J Neuroradiol. 2020 Aug;41(8):1377-1379. doi: 10.3174/ajnr.A6642. Epub 2020 Jun 18.
3
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.高流量鼻导管给氧治疗严重新型冠状病毒肺炎所致呼吸衰竭：一项真实世界观察性研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016.
4
COVID-19 infection with extensive thrombosis: A case of phlegmasia cerulea dolens.新型冠状病毒肺炎感染伴广泛血栓形成：1例股青肿病例。
Am J Emerg Med. 2020 Sep;38(9):1978.e1-1978.e3. doi: 10.1016/j.ajem.2020.05.022. Epub 2020 May 15.
5
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.新型冠状病毒感染中的急性门静脉血栓形成：一例报告
Am J Gastroenterol. 2020 Jul 1;115(7):1140-1142. doi: 10.14309/ajg.0000000000000711.
6
Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19.与新型冠状病毒肺炎相关的脑静脉血栓形成的潜在潜在机制。
J Neuroradiol. 2020 Nov;47(6):473-474. doi: 10.1016/j.neurad.2020.06.009. Epub 2020 Jun 26.
7
COVID-19 Pneumonia Hospitalizations Followed by Re-Presentation for Presumed Thrombotic Event.新冠病毒肺炎住院治疗后再次出现疑似血栓形成事件。
Chest. 2020 Oct;158(4):1665-1668. doi: 10.1016/j.chest.2020.06.023. Epub 2020 Jun 23.
8
Portal Vein Thrombosis in a Patient With COVID-19.一名新冠肺炎患者的门静脉血栓形成
Am J Gastroenterol. 2020 Sep;115(9):1545-1546. doi: 10.14309/ajg.0000000000000781.
9
An alternative continuous positive airway pressure system for COVID-19 patients.一种用于新冠肺炎患者的替代性持续气道正压通气系统。
Br J Anaesth. 2020 Sep;125(3):e310-e313. doi: 10.1016/j.bja.2020.05.035. Epub 2020 Jun 1.
10
Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice.无创通气治疗新型冠状病毒肺炎所致早期低氧性呼吸衰竭：将鼻持续气道正压通气作为首选方案
Crit Care. 2020 Jun 11;24(1):333. doi: 10.1186/s13054-020-03054-7.
引用本文的文献
1
FcRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation.在新冠疫苗诱导的免疫性血栓性血小板减少症、肝素诱导的血小板减少症、链激酶和酰化纤溶酶原-链激酶激活剂复合物诱导的血小板激活中发现的FcRIIa依赖性血小板激活。
Front Cardiovasc Med. 2023 Nov 15;10:1282637. doi: 10.3389/fcvm.2023.1282637. eCollection 2023.
2
COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication?肝硬化患者中的 COVID-19：门静脉血栓形成是否为潜在并发症？
Can J Gastroenterol Hepatol. 2022 Mar 26;2022:5900468. doi: 10.1155/2022/5900468. eCollection 2022.
3
Compressive ultrasound can predict early pulmonary embolism onset in COVID patients.压缩超声可预测 COVID 患者早期肺栓塞的发生。
J Ultrasound. 2022 Sep;25(3):571-577. doi: 10.1007/s40477-021-00625-4. Epub 2022 Jan 9.
4
Review of COVID-19, part 2: Musculoskeletal and neuroimaging manifestations including vascular involvement of the aorta and extremities.COVID-19 回顾：第 2 部分：肌肉骨骼和神经影像学表现，包括主动脉和四肢的血管受累。
Clin Imaging. 2021 Nov;79:300-313. doi: 10.1016/j.clinimag.2021.08.003. Epub 2021 Aug 8.
5
Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19.COVID-19 继发上肢深静脉血栓形成复发。
Viruses. 2021 May 11;13(5):878. doi: 10.3390/v13050878.
6
The severity and atypical presentations of COVID-19 infection in pediatrics.儿童 COVID-19 感染的严重性和非典型表现。
BMC Pediatr. 2021 Mar 25;21(1):144. doi: 10.1186/s12887-021-02614-2.
7
Re: "Endothelitis in COVID-19-Positive Patients after Extremity Amputation for Acute Thrombotic Events".关于：“COVID-19阳性患者因急性血栓事件行肢体截肢术后的内皮炎”
Ann Vasc Surg. 2021 May;73:e6-e7. doi: 10.1016/j.avsg.2021.01.067. Epub 2021 Feb 3.
8
Immune reactivity during COVID-19: Implications for treatment.COVID-19 期间的免疫反应：对治疗的影响。
Immunol Lett. 2021 Mar;231:28-34. doi: 10.1016/j.imlet.2021.01.001. Epub 2021 Jan 6.
9
Re-organization of the Vascular Surgery Department During the Acute Phase of the COVID19 Outbreak: Lessons Learned and Future Perspectives.COVID19 疫情期间血管外科部门的重组：经验教训和未来展望。
Ann Vasc Surg. 2021 Apr;72:191-195. doi: 10.1016/j.avsg.2020.12.001. Epub 2021 Jan 13.
10
Acute portal vein thrombosis secondary to COVID-19: a case report.COVID-19 继发急性门静脉血栓形成：一例报告。
BMC Gastroenterol. 2020 Nov 19;20(1):386. doi: 10.1186/s12876-020-01518-2.
本文引用的文献
1
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
2
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
3
Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure.在上市后监测中，分析重组人血栓调节蛋白用于治疗伴有感染性疾病和血液系统恶性肿瘤的弥散性血管内凝血（DIC）时，DIC的缓解与器官衰竭治疗结局之间的关联。
Thromb J. 2020 Feb 7;18:2. doi: 10.1186/s12959-020-0216-6. eCollection 2020.
4
Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense.凝血，一个古老的丝氨酸蛋白酶级联反应，在早期免疫防御中发挥新的功能。
Blood. 2011 Sep 1;118(9):2589-98. doi: 10.1182/blood-2011-02-337568. Epub 2011 May 25.
Zotero 插件